Evommune EVMN Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|
| Revenue by Product | ||||
| Hemp Derived Products | $60.89K-51.1% | $124.62K-22.4% | $160.53K-4.2% | |
| Nutraceuticalsupplements | $6.61M+1.8% | $6.49M-2.3% | $6.64M+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Evommune break its business down?
- Evommune (EVMN) reports revenue by product across 2 parts — Hemp Derived Products and Nutraceuticalsupplements. Each is extracted from the segment footnotes and tracked over time.
- Where does Evommune 's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Evommune 's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
